Drug Trial Radar · NCT05890001
A Study to Evaluate the Long-Term Safety of BLI5100 in Patients With Gastroesophageal Reflux Disease
Last checked: Nov 19, 2026Latest source record: Sep 26, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
400
Actual
Start
Apr 5, 2023
Primary completion
Oct 8, 2024
Study completion Oct 8, 2024
Sponsor
- Lead sponsor
- Braintree LaboratoriesIndustry
- Sponsor type
- Industry
- First posted
- Jun 5, 2023
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 85 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The objective of this study is to evaluate the safety of up to 12 months (52 weeks) of once daily oral administration of BLI5100 in patients with non-erosive reflux disease (NERD) or healed erosive esophagitis (EE).
Conditions
- Non-erosive Reflux Disease
- Erosive Esophagitis
Interventions
BLI5100Drug
Patients will take BLI5100 once daily, orally, for up to 29 weeks.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Frequency of treatment-emergent adverse eventsTime frame: 31 Weeks
Locations
60 sites in 1 country. Site status is shown where the registry gives one.
Research Site 24
Huntsville, Alabama
Research Site 62
Phoenix, Arizona
Research Site 27
Tucson, Arizona
Research Site 87
Little Rock, Arkansas
Research Site 117
North Little Rock, Arkansas
Research Site 94
Chula Vista, California
Research Site 10
Huntington Park, California
Research Site 55
La Mesa, California
Research Site 72
Los Angeles, California
Research Site 54
Los Angeles, California
Research Site 13
Santa Ana, California
Research Site 41
Santa Maria, California
Research Site 108
Cooper City, Florida
Research Site 91
Doral, Florida
Research Site 78
Homestead, Florida
Research Site 23
Maitland, Florida
Research Site 38
Miami, Florida
Research Site 43
Miami, Florida
Research Site 67
Miami, Florida
Research Site 92
Miami, Florida
Research Site 71
Miami, Florida
Research Site 42
Miami Lakes, Florida
Research Site 17
New Port Richey, Florida
Research Site 90
Ocoee, Florida
Research Site 05
Palmetto Bay, Florida
Research Site 11
Sunrise, Florida
Research Site 46
Viera, Florida
Research Site 59
Sandy Springs, Georgia
Research Site 01
Gurnee, Illinois
Research Site 02
Oak Lawn, Illinois
Research Site 45
Houma, Louisiana
Research Site 12
Marrero, Louisiana
Research Site 48
Metairie, Louisiana
Research Site 34
New Orleans, Louisiana
Research Site 111
Chesterfield, Missouri
Research Site 06
Las Vegas, Nevada
Research Site 64
Reno, Nevada
Research Site 35
Brooklyn, New York
Research Site 07
Great Neck, New York
Research Site 28
Hartsdale, New York
Showing 40 of 60 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.